AKR1A1 and Kidney Disease: Promise and Perils of the Multiverse
Diabetes
.
2024 Jul 1;73(7):1046-1047.
doi: 10.2337/dbi24-0022.
Author
Matthew D Breyer
1
Affiliation
1
Johnson and Johnson R&D, LLC, Cambridge, MA.
PMID:
38900956
DOI:
10.2337/dbi24-0022
No abstract available
Publication types
Editorial
Comment
MeSH terms
Aldehyde Reductase* / antagonists & inhibitors
Aldehyde Reductase* / genetics
Aldehyde Reductase* / metabolism
Animals
Diabetic Nephropathies
Humans
Substances
Aldehyde Reductase
Grants and funding
Janssen R&D LLC
Johnson and Johnson Pharmaceutical Research and Development